The Board Meeting to be held on 14/11/2025 has been revised to 14/11/2025 The Board Meeting to be held on 14/11/2025 has been revised to 14/11/2025
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics has scheduled a board meeting on Friday, November 14, 2025 to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025. The filing also mentions that any other business may be taken up with the Chairperson's permission. The trading window for insiders remains closed until 48 hours after the results are publicly declared. No actual financial numbers or outcomes are disclosed in this intimation, and the headline's mention of 'revision' appears to be a duplicate entry rather than a substantive change.
No immediate impact on shareholders — this is a routine pre-results compliance filing. Investors should monitor the actual Q2/H1 FY26 results expected on or shortly after November 14, 2025 for any meaningful business signals.